Sign in

CIK 0001374690

  • Non-accelerated filer
  • Smaller reporting company

Larimar Therapeutics, Inc.

Sign in to watch
Ticker
LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
203857670
Phone
+1 844-511-9056
Business address
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA, 19004
Former names
ZAFGEN, INC., ZAFGEN INC
Open-market buys, last 90 days
$392,144
in 8 filings
Open-market sales, last 90 days
$0
in 0 filings

Net +$392,144. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 30 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-11-11 Celano Michael Chief Financial Officer Purchase +18,460 $2.71 $50K 234,245
2026-01-26 Celano Michael Chief Financial Officer Grant or award +37,604 215,785
2026-01-26 Celano Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +225,622 225,622
2025-01-22 Celano Michael Chief Financial Officer Grant or award +34,185 178,181
2025-01-22 Celano Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +205,111 205,111
2024-01-17 Celano Michael Chief Financial Officer Grant or award +31,250 143,996
2024-01-17 Celano Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +187,500 187,500
2023-05-17 Celano Michael Chief Financial Officer Purchase +5,000 $3.73 $19K 112,746
2023-01-31 Celano Michael Chief Financial Officer Grant or award +76,000 107,746
2023-01-31 Celano Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +120,000 120,000
2022-09-16 Celano Michael Chief Financial Officer Purchase +31,746 $3.15 $100K 31,746
2022-05-10 Celano Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +20,000 20,000
2022-01-18 Celano Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +80,000 80,000
2021-01-19 Celano Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +42,000 42,000
2020-09-29 Celano Michael Chief Financial Officer Grant or award · Stock Option (right to buy) +84,100 84,100
2020-05-28 Celano Michael Chief Financial Officer Grant or award · Stock Option (Right to Buy) +60,479 60,479

Page 1 of 1 · 16 trades